HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > LegalView

Print e mail rss del Y! myWeb Tweet
 

LegalView Blog Announces Recruitment of Mesothelioma Victims for New Clinical Trial Combining Chemotherapy and Radiation Treatments

LegalView made available the details of a new clinical trial, which will test chemotherapy and radiation methods rather than surgery as a treatment among mesothelioma patients. Victims of mesothelioma cancer are currently being recruited for the study, wh

(EMAILWIRE.COM, July 12, 2008 ) Denver, CO - LegalView, the most comprehensive legal resource available on the Web, released details of a newly advertised clinical trial that will target radiation and chemotherapy treatments rather than surgery for mesothelioma patients. The study is for individuals suffering from malignant pleural mesothelioma, which is often considered the most deadly form of mesothelioma cancer. The trial will take approximately 13 weeks and will involve exploratory surgery as well as chemotherapy and radiotherapy, which will be administered directly into the affected area.

Mesothelioma cancer is caused by the inhalation of asbestos fibers and dust, which can occur anywhere asbestos has been previously used, although it is most commonly found in insulation within the construction industry. Individuals who have been affected by mesothelioma cancer are advised to seek out a mesothelioma law firm (http://mesothelioma.legalview.com) that can provide victims with a better understanding of the details of a potential mesothelioma lawsuit (http://mesothelioma.legalview.com). An experienced law firm will also provide a plethora of mesothelioma lawyers (http://mesothelioma.legalview.com) to deal with the specifics of an individual's asbestos-related case.

The new clinical trial aims to find a successful alternative treatment to surgery. Currently, mesothelioma cancer has a grim prognosis, as it is usually not successfully treatable and most often the cancerous portions of the lung are removed via a surgical procedure, which doesn't commonly provide a prolonged life for victims. Additionally, according to the details of the study, surgery "may even lead to a worsened pulmonary function" among patients. For more information on developing litigation related to mesothelioma and asbestos, individuals should locate a mesothelioma attorney (http://mesothelioma.legalview.com) who can provide legal consultation on the details of an individual victim's lawsuit.

For information on locating an experienced lawyer, visit LegalView's homepage, which also offers additional information on an array of legal topics including the heavily discussed pharmaceutical controversies that have recently threatened patients. For example, prescription drugs such as Levaquin, Avandia and Chantix have become hot topics in many news reports for the alleged side effects and potential risks associated with each drug.

Levaquin is an anti-bacterial prescription drug that is part of the fluoroquinolone drug family. Levaquin is used for an array of conditions ranging from urinary tract infections to bronchitis to gonorrhea and Chlamydia to pneumonia. According to several scientific studies recently released, consumption of the drug may lead to Levaquin-induced Achilles tendonitis among patients who take the drug for short- to long-term periods of time. One study published in the Journal of the American Board of Family Medicine suggested that patients who had taken the drug anywhere from 6 months to two years and prior may even be at risk for the Levaquin tendon rupture (http://levaquin.legalview.com). Additionally Cipro, another of the fluoroquinolone drugs, has also been found to pose a potential risk for tendonitis and tendon rupture and has thus been given a "black box" Cipro FDA warning (http://cipro.legalview.com). The "black box warning is the strongest warning the FDA can put on a drug.

Finally, Chantix, one of the most recently released prescription drugs, is used to aid patients attempting to quit smoking. In late 2007, hundreds of patients of the smoking-cessation drug had reported unusual Chantix side effects (http://chantix.legalview.com) that included mood swings, erratic behavior, depression, suicidal thoughts and tendencies. An additional 37 cases of suicide among Chantix patients had also been reported to the FDA, according to an FDA Public Health Advisory from 2008. To learn more about these issues as well as many others, visit the LegalView homepage.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Contact Information:
LegalView
Katie Kelley
Tel: 720-771-3246
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Press Release Keywords:

lung cancer, lawyer, attorney, legal consultation, asbestos exposure, asbestos dust, asbestos fibers, mesothelioma law firm, mesothelioma lawsuit, mesothelioma lawyer, mesothelioma attorney, asbestos attorney, asbe

Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012